Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
RMD Transcript
ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
Positive1-29
The earnings call summary indicates strong financial performance with double-digit revenue growth, gross margin expansion, and increased operating profit. The Q&A section reveals positive sentiment towards new product launches and strategic initiatives like AI integration and market expansion. Despite higher SG&A expenses due to acquisitions and promotions, the overall outlook remains optimistic. The shareholder return plan, including dividends and buybacks, further supports a positive sentiment. However, uncertainty about Philips' market reentry and SG&A expenses slightly tempers the outlook, resulting in a positive but not strong positive prediction.
ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript
Positive10-30
The earnings call summary reveals strong financial performance, especially in product development and shareholder return plans with increased dividends and share buybacks. The Q&A section highlights strategic expansions and acquisitions, enhancing growth prospects. Despite some unclear management responses, the overall sentiment is positive due to the focus on innovation, market expansion, and robust growth strategies. The positive impact of new product launches and strategic acquisitions outweighs concerns about restructuring costs and tax impacts, suggesting a positive stock price movement.
ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Neutral9-23
RMD Slides
RMD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
